-
Recent Posts
- December 01 2013 – Human stem cells converted to functional lung cells
- November 30 2013 – Keyhole lung transplant performed on 60-year-old in Chennai
- November 27 2013 – FibroGen Announces Observations of Possible Disease Stabilization and Improvement in Interim Analysis of Phase 2 Study of FG-3019
- November 15 2013 – Enzo Biochem Announces Study in Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, a Deadly Human Disease with No Effective Treatment Options, to Presence of a Monkey Virus
- November 10 2013 – Research by Saint Louis University scientists offers way to disrupt fibrosis
Recent Comments
- Fish With Captain Frank on June 20 2012 MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)
- Raymond on June 9 2011 – Ascend Trial – Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Johng182 on InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
- Johnf73 on InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
- extreme rush on June 28 2012 Grasping at Straws while Gasping for Air
Archives
Categories
Meta
Monthly Archives: April 2011
April 20 2011 NIH News – Common genetic variant linked to pulmonary fibrosis risk
Common genetic variant linked to pulmonary fibrosis risk NIH-funded genome study could lead to increased knowledge of lung-scarring diseases. Scientists funded by the National Institutes of Health have identified a common genetic variant associated with substantially increased risk of developing … Continue reading
Posted in Uncategorized
Leave a comment
April 19 2011 Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
San Diego, CA – Apr 19, 2011 — Amira Pharmaceuticals, Inc. announced today that AM152, the company’s lead LPA1 antagonist, has been granted an orphan drug designation by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary … Continue reading
Posted in Uncategorized
1 Comment
April 7 2011 – UVM to conduct clinical trial for new idiopathic pulmonary fibrosis treatment
ImmuneWorks, Inc. recently partnered with The University of Vermont in Burlington to conduct a clinical trial for a new idiopathic pulmonary fibrosis (IPF) treatment. The Phase I clinical trial will evaluate the safety, tolerability, and biologic effects of three doses … Continue reading
Posted in Uncategorized
Leave a comment
April 1 2011 Revised Lung Allocation System Transformed Transplantation Dynamics
LAS VEGAS – The 2005 revision of the lung allocation system for U.S. lung transplants succeeded, resulting in fewer patients dying while on the lung waiting list, Dr. Robert M. Kotloff said at the annual meeting of the National Association … Continue reading
Posted in Uncategorized
Leave a comment
March 30 2011 MUSC launches new lung transplant program
CHARLESTON, SC (WCSC) – MUSC performed its first lung transplant in more than 15 years March 9. Before the program was approved, anyone needing a lung transplant had to travel out of state. Full Article: http://www.live5news.com/story/14317398/musc-launches-new-lung-transplantation-program www.ipftoday.com
Posted in Uncategorized
Leave a comment
March 24 2011 A simple, yet promising treatment for pulmonary fibrosis
A group of researchers at the Institute for Biomedical Research of Barcelona is working on a pioneering treatment for idiopathic pulmonary fibrosis based on an innovative hypothesis: the transplant of type II pneumocytes, the cells that allow the lung to … Continue reading
Posted in Uncategorized
Leave a comment
March 23 2011 MicroRNAs: A potential new frontier for medicine
New York, NY, March 23, 2011 Since their discovery in the 1990s, microRNAs have proven to play a complex role in normal and abnormal functioning of many organ systems. In the April issue of Translational Research, entitled “MicroRNAs: A Potential … Continue reading
Posted in Uncategorized
Leave a comment